Filing Details
- Accession Number:
- 0001104659-25-074386
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-05 20:20:22
- Reporting Period:
- 2025-08-01
- Filing Date:
- 2025-08-05
- Accepted Time:
- 2025-08-05 20:20:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1657312 | Verona Pharma Plc | VRNA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640073 | Martin Edwards | 3 More London Riverside London X0 SE1 2RE | Yes | No | No | No |
Transaction Summary
| Sold: | 10,808 shares | Avg. Price: $13.14 | Total Value: $142,057.11 |
| Number of Shares After Transactions: | 157,992 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2025-08-01 | 24,000 | $0.00 | 168,800 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2025-08-01 | 10,808 | $13.14 | 157,992 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units | Disposition | 2025-08-01 | 24,000 | $0.00 | 24,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 72,000 | No | 4 | M | Direct |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- The sale reported in the Form 4 represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the Reporting Person's tax withholding obligation upon the vesting of the restricted stock units ("RSUs").
- The price reported represents the sale price of the ADSs divided by eight (8).
- Consists of 157,992 Ordinary Shares represented by 19,749 ADSs.
- Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date.
- The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date.
Billionaire Hedge Funds
